BEONE MEDICINES LTD. Restricted Cash and Cash Equivalents, Current
BEONE MEDICINES LTD. (ONC) had Restricted Cash and Cash Equivalents, Current of $161.05 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Restricted Cash and Cash Equivalents, Current $161.05M.
- 2026-03-31: Restricted Cash and Cash Equivalents, Current $40.84M.
- 2025-12-31: Restricted Cash and Cash Equivalents, Current $41.28M.
- 2025-09-30: Restricted Cash and Cash Equivalents, Current $52.99M.
| Period end | Restricted Cash and Cash Equivalents, Current |
|---|---|
| 2026-06-30 | $161.05M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $40.84M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $41.28M 10-K · filed 2026-02-26 |
| 2025-09-30 | $52.99M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $15.80M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $11.33M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $9.31M 10-K · filed 2026-02-26 |
| 2024-09-30 | $9.28M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $23.16M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $11.45M 10-Q · filed 2025-05-07 |
| 2023-12-31 | $11.47M 10-K · filed 2026-02-26 |
| 2023-09-30 | $11.55M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $9.69M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $159.00K 10-Q · filed 2024-05-08 |
| 2022-12-31 | $196.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $191.00K 10-Q · filed 2023-11-09 |
| 2022-06-30 | $333.00K 10-Q · filed 2023-08-02 |
| 2022-03-31 | $330.00K 10-Q · filed 2023-05-04 |
| 2021-12-31 | $328.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $330.00K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $310.00K 10-Q · filed 2022-08-08 |
| 2021-03-31 | $305.00K 10-Q · filed 2022-05-09 |
| 2020-12-31 | $307.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $295.00K 10-Q · filed 2021-11-04 |
| 2020-06-30 | $283.00K 10-Q · filed 2021-08-05 |
| 2020-03-31 | $282.00K 10-Q · filed 2021-05-06 |
| 2019-12-31 | $288.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $14.27M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $14.57M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $14.90M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $14.54M 10-K · filed 2021-02-25 |
| 2018-09-30 | $14.56M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $31.59M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $17.46M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 |